SARS-CoV-2
Showing NaN - NaN of 9
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)
Recruiting
- SARS-CoV-2
- Influenza
- Fluarix
- +8 more
-
Chandler, Arizona
- +68 more
Apr 24, 2023
SARS-CoV-2 Trial in United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Banning, California
- +48 more
Jan 5, 2023
SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273.211
- +6 more
-
Sacramento, California
- +22 more
Nov 16, 2022
SARS-CoV-2 Trial in Canada, United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Birmingham, Alabama
- +89 more
Oct 7, 2022
SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- Influenza
- mRNA-1073
- +3 more
-
Hollywood, Florida
- +13 more
Oct 5, 2022
SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)
Active, not recruiting
- SARS-CoV-2
- mRNA-1283
- +2 more
-
Chandler, Arizona
- +4 more
Sep 22, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)
Recruiting
- SARS-CoV-2
- +3 more
- mRNA-1273
- +4 more
-
Hollywood, Florida
- +7 more
May 25, 2022